Performance of a PLK1‐based immune risk model for prognosis and treatment response prediction in breast cancer

OBJECTIVE: Polo‐like kinase 1 (PLK1), a serine/threonine‐protein kinase, functions as a potent oncogene in the initiation and progression of tumor. The aim of this study is to assess potential correlations between PLK1 expression and immune infiltration in breast cancer (BRCA) and construct a PLK1‐b...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yan, You, Yiqing, Wu, Qiaoling, Wu, Jing, Lin, Shujing, Sun, Yang, Cui, Zhaolei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10225204/
https://www.ncbi.nlm.nih.gov/pubmed/36951624
http://dx.doi.org/10.1002/cam4.5813

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10225204/
https://www.ncbi.nlm.nih.gov/pubmed/36951624
http://dx.doi.org/10.1002/cam4.5813

Ejemplares similares